MRS-1845;MRS1845;MRS 1845
|
|
|
- CAS号:
- 544478-19-5
- 英文名:
- MRS 1845
- 英文别名:
- MRS 1845;MRS1845,MRS-1845;N-PROPARGYLNITRENDIPENE;MRS-1845;MRS1845;MRS 1845;MRS 1845 >=95% (HPLC), solid;1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-1-(2-propynyl)-3,5-pyridinedicarboxylicacidethylmethylester;1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-1-(2-PROPYNYL)-3,5-PYRIDINEDICARBOXYLIC ACID ETHYL, METHYL ESTER;3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-1-(2-propyn-1-yl)-, 3-ethyl 5-methyl ester
- 中文名:
- MRS-1845;MRS1845;MRS 1845
- 中文别名:
- 化合物 T12108
- CBNumber:
- CB4361853
- 分子式:
- C21H22N2O6
- 分子量:
- 398.41
- MOL File:
- 544478-19-5.mol
|
|
|
MRS-1845;MRS1845;MRS 1845化学性质
-
沸点:
-
511.0±50.0 °C(Predicted)
-
|
-
密度:
-
1.238±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
2-8°C
-
|
-
溶解度:
-
DMSO: 13 mg/mL at 60 °C, soluble
-
|
-
形态:
-
solid
-
|
-
酸度系数(pKa):
-
0.03±0.70(Predicted)
-
|
-
颜色:
-
yellow
-
|
MRS-1845;MRS1845;MRS 1845性质、用途与生产工艺
MRS1845 是一种选择性钙池调控钙离子通道 (SOC) 抑制剂，IC50 为 1.7 μM。MRS1845 是一种 ORAI1 抑制剂。
Treatment with MRS1845 (10 μM) virtually disrupts the effects of β-glycerophosphate on store-operated Ca
2+
entry (SOCE).
MRS1845 (10 μM) significantly decreases SOCE and virtually abolishes the increase of SOCE following placental growth factor (PlGF) treatment.
MRS-1845;MRS1845;MRS 1845
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/25 | HY-103310 | MRS1845 | | 5 mg | 1100元 |
| 2024/01/25 | HY-103310 | MRS1845 | | 10 mM * 1 mLin DMSO | 1210元 |
MRS-1845;MRS1845;MRS 1845
生产厂家
544478-19-5, MRS-1845;MRS1845;MRS 1845 相关搜索:
- API
- Calcium channel
- BioChemical
- Cell Signaling and Neuroscience
- Calcium Channel Modulators
- Cell Biology
- Voltage-gated Ion Channels
- Ion Channels
- Inhibitors and Activators
- 化合物 T12108
- 544478-19-5
- MRS1845,MRS-1845
- MRS 1845 >=95% (HPLC), solid
- 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-1-(2-propyn-1-yl)-, 3-ethyl 5-methyl ester
- MRS-1845;MRS1845;MRS 1845
- 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-1-(2-propynyl)-3,5-pyridinedicarboxylicacidethylmethylester
- 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-1-(2-PROPYNYL)-3,5-PYRIDINEDICARBOXYLIC ACID ETHYL, METHYL ESTER
- MRS 1845
- N-PROPARGYLNITRENDIPENE